Ultrasound Wound Therapy

Diabetes & Wound Care

UltraMISTĀ® therapy is a painless, no-contact, low-frequency, ultrasound therapy that has been clinically proven to promote healing across a wide range of chronic and acute wounds.Ā 


Primary Care and Wound Care

Primary care providers should consider using the UltraMISTĀ® System before referring more complicated wounds to wound care clinics. This clinically proven, easy-to-use, portable, and painless advanced wound care technology is painless and can jump-start cellular healing and reduce inflammation, bacteria, and biofilms while promoting perfusion and vasodilation. The best part is that the system uses saline to deliver the ultrasound to the wound site without direct contact with the tissue, making it a non-invasive and safe option for patients. Patient satisfaction is high and outcomes are excellent.

Healthcare professionals have widely used the UltraMISTĀ® System for over a decade and have shown remarkable results in shortening the time to wound closure, preventing recurrence, and reducing pain. A vast array of clinical evidence supports the effectiveness of this treatment. By incorporating the UltraMISTĀ® System in their practice, primary care providers can provide their patients with cutting-edge wound care treatment backed by clinical data, thus improving patient outcomes and saving them the trouble of visiting wound care clinics for more complicated wounds.

Benefits of UltraMIST:

The mobile unit fits seamlessly within your office and clinic work flows and improves patient satisfaction.


Administered by trained healthcare personnel to thousands of patients for more than a decade and supported by a vast array of clinical evidence, the UltraMISTĀ® Systemā€™s acoustic wave therapy promotes healing by controlling inflammation and reducing bacteria in the wound bed while increasing angiogenesis. Further, promoting healing increases perfusion through vasodilation, ultimately increasing oxygen and nutrients in the tissue.

The UltraMISTĀ® Ā System mechanically removes barriers and promotes healing in various wound types. Indications include, but are not limited to, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical, burn, and deep tissue injuries. It also reduces and removes many bacteria, including biofilms, while preserving healthy structures.Ā 

By activating the bodyā€™s normal regeneration process, the UltraMISTĀ® System offers significant wound healing advantages. First, it reduces barriers to healing by reducing bacterial overgrowth, disrupting bacterial biofilms, and controlling inflammation. At the same time, UltraMISTĀ® System therapy promotes healing through vasodilation and by accelerating angiogenesis. A meta-analysis of clinical evidence in cases including diabetic foot, ischemic, neuropathic, venous, multifactorial, pressure, surgical, and traumatic ulcers shows that wound closure increased from 24% with standard care to 42% with UltraMISTĀ® use over a 12-week interval.

To accelerate wound healing even more, in between the UltraMISTĀ® System treatments, other standard or advanced wound therapies may be incorporated into the treatment plan ā€” at the discretion of the wound care professional. The result? Faster relief and better quality of life for your patients with less time and resources on costly treatments that donā€™t work. These savings make the UltraMISTĀ® System a financially viable solution for the patient, the provider, and the healthcare system.

UltraMISTĀ® achieved an 85% Area Reduction in 7 weeks across a wide range of chronic and acute woundsĀ 

Simply Better